AstraZeneca Whale Racing With Minnow to Develop Lung Cancer Drug

The race to develop a new class of lung-cancer medicines is pitting one of the world’s biggest drugmakers against a five-year-old startup.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.